Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying

The Dow Jones index closed higher by 0.2% on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

Bespoke Extracts

• The Trade: Bespoke Extracts, Inc. BSPK CEO Michael Feinsod bought a total of 2,000 shares at an average price of $0.13. To acquire these shares, it cost around $268.
• What's Happening: The company’s stock lost around 48% over the past six months.
• What Bespoke Extracts Does: Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.

Ocuphire Pharma

• The Trade: Ocuphire Pharma, Inc. OCUP CEO George Magrath acquired a total of 5,000 shares at an average price of $1.75. To acquire these shares, it cost around $8,773.
• What's Happening: On May 10, Ocuphire Pharma posted a wider-than-expected quarterly loss.
• What Ocuphire Pharma Does: Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders.

Duos Technologies

• The Trade: Duos Technologies Group, Inc. DUOT CEO Charles Parker Ferry acquired a total of 3,773 shares at an average price of $2.70. The insider spent around $10,187 to buy those shares.
• What's Happening: On May 13, Duos Technologies Group reported weaker than expected first-quarter sales.
• What Duos Technologies Does: Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs.

Read More: Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month